The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...
from NDTV News - India-news https://ift.tt/2XmSgN8
from NDTV News - India-news https://ift.tt/2XmSgN8
India
![India]()
Reviewed by Latest trending news
on
August 02, 2020
Rating:
No comments:
Note: only a member of this blog may post a comment.